{"result": "(\"entity\"<|>LANCET DIABETES ENDOCRINOL<|>ORGANIZATION<|>Lancet Diabetes Endocrinol is a medical journal that publishes research related to diabetes and endocrinology.)\n##\n(\"entity\"<|>EUROPEAN HEART JOURNAL<|>ORGANIZATION<|>Eur Heart J is a medical journal that focuses on cardiovascular medicine and research.)\n##\n(\"entity\"<|>NEW ENGLAND JOURNAL OF MEDICINE<|>ORGANIZATION<|>N Engl J Med is a prestigious medical journal that publishes research and reviews in all areas of medicine.)\n##\n(\"entity\"<|>METABOLISM<|>ORGANIZATION<|>Metabolism is a journal that publishes research on metabolic processes and related diseases.)\n##\n(\"entity\"<|>NON-ALCOHOLIC FATTY LIVER DISEASE<|>EVENT<|>Non-alcoholic fatty liver disease (NAFLD) is a condition characterized by the accumulation of fat in the liver without alcohol consumption.)\n##\n(\"entity\"<|>OBESITY<|>EVENT<|>Obesity is a medical condition involving excess body fat that increases the risk of health problems.)\n##\n(\"entity\"<|>CIRRHOSIS<|>EVENT<|>Cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism.)\n##\n(\"entity\"<|>HEPATOCARCINOMA<|>EVENT<|>Hepatocarcinoma is a type of liver cancer that occurs in the setting of chronic liver disease, often associated with cirrhosis.)\n##\n(\"relationship\"<|>LANCET DIABETES ENDOCRINOL<|>EUROPEAN HEART JOURNAL<|>Both journals publish research related to health conditions that can be influenced by obesity and metabolic health.<|>3)\n##\n(\"relationship\"<|>LANCET DIABETES ENDOCRINOL<|>NEW ENGLAND JOURNAL OF MEDICINE<|>Both journals publish significant research on diseases related to metabolic health and liver conditions.<|>3)\n##\n(\"relationship\"<|>EUROPEAN HEART JOURNAL<|>NEW ENGLAND JOURNAL OF MEDICINE<|>Both journals focus on cardiovascular health, which can be affected by obesity and liver diseases.<|>3)\n##\n(\"relationship\"<|>NEW ENGLAND JOURNAL OF MEDICINE<|>METABOLISM<|>Both journals publish research on metabolic diseases, including obesity and liver conditions.<|>3)\n##\n(\"relationship\"<|>NON-ALCOHOLIC FATTY LIVER DISEASE<|>OBESITY<|>Obesity is a major risk factor for developing non-alcoholic fatty liver disease.<|>8)\n##\n(\"relationship\"<|>NON-ALCOHOLIC FATTY LIVER DISEASE<|>CIRRHOSIS<|>Non-alcoholic fatty liver disease can progress to cirrhosis in some patients.<|>7)\n##\n(\"relationship\"<|>CIRRHOSIS<|>HEPATOCARCINOMA<|>Cirrhosis is a significant risk factor for the development of hepatocarcinoma.<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: follow-up from\n          a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714-24.                                                               Referencias:\n        • Lassale C, Tzoulaki I, Moons KGM, Sweeting M, Boer J, Johnson L, et al. Separate and combined associations of obesity and            • Aller R, Fernández-Rodríguez C, Oreste lo Iacono, et al. Documento de consenso. Manejo de la enfermedad hepática grasa\n          metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J. 2018;39:397-406.                       no alcohólica (EHGNA). Guía de práctica clínica. Gastroenterol Hepatol. 2018;41(5):328-49.\n                                                                                                                                               • Diehl AM, Day C. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis. N Engl J Med. 2017;377:2063-72.\n                                                                                                                                               • Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.\n                                                                                                                                                 Metabolism. 2019;92:82-97.\n        ¿Cuál de las siguientes respuestas respecto a la enfermedad hepática grasa no                                                          • Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment\n     4                                                                                                                                           strategies. Lancet Diabetes Endocrinol. 2019;7:313-24.\n        alcohólica (EHGNA) en obesidad es cierta?\n        A. La esteatohepatitis es más frecuente en pacientes diabéticos.                                                                       La relación de la obesidad con la insuficiencia                        cardíaca se        relaciona con:\n        B. Con el paso del tiempo no todos los pacientes con esteatosis hepática evolucionan a                                              5\n            esteatohepatitis.                                                                                                                  A. Un incremento del volumen circulante.\n        C. La prevalencia de esteatosis hepática en obesos es superior al 50%.                                                                 B. Un aumento de leptina, aldosterona y neprilisina que favorece la inflamación cardíaca\n        D.  Todas las respuestas son ciertas.                                                                                                      y la fibrosis.\n                                                                                                                                               C. Una sobreexpresión de citocinas como la adiponectina relacionadas con hipertrofia\n        COMENTARIO                                                                                                                                 ventricular.\n        La EHGNA (NALFD por sus siglas en inglés de non alcoholic liver fatty disease) es la acu-                                              D.  Desregulación del sistema adrenérgico que favorece la arritmia cardíaca.\n        mulación excesiva de grasa hepática (mediante histología o técnicas de imagen). El hígado\n        graso no alcohólico o esteatosis hepática implica la presencia de esteatosis en un 5% o                                                COMENTARIO\n        más    de los hepatocitos sin evidencia              de lesión hepatocelular (o            balonización). En la         estea-         La obesidad se asocia a cambios hemodinámicos y de remodelado de la estructura cardía-\n        tohepatitis      (en inglés NASH, de nonalcoholic steatohepatitis), además                            de  la  presencia de             ca como consecuencia de la liberación de ácidos grasos libres y citocinas que conducen a\n        esteatosis en el 5% o más de los hepatocitos, existe inflamación con lesión hepatocitaria                                              incrementar la resistencia a la insulina, mayor actividad del sistema renina-angiotensina y\n        (p.  ej., balonización) con/sin fibrosis adicional.                                                                                    del sistema nervioso simpático (tabla 1).\n        Siguiendo      “la regla del 25%”,         aproximadamente            un 25% de la población adulta presenta                           Pero, sin duda, los péptidos natriuréticos tienen un papel en la regulación del tono vascular\n        esteatosis EHGNA. De estos, un 25% (2-3% de la población) desarrollará esteatohepatitis                                                y del sistema renina-angiotensina, favoreciendo la excreción renal de sodio y agua. Pero,\n        (NASH). Y a su vez, entre esos sujetos, otro 25% progresará a cirrosis. A partir de aquí, un                                           también, los péptidos natriuréticos ejercen acciones beneficiosas metabólicas, como au-\n        porcentaje no conocido puede generar un hepatocarcinoma.\n\n\n\n422                                                                                                                                                                                                                                                                              423\n---\n                                                                                                                                                                                                                             OBESIDAD,                   LÍPIDOS                          8\n                                                                                                                                                                                            Y TRASTORNOS ELECTROLÍTICOS\n\n\n\n     mentar       la oxidación       de los     ácidos     grasos, favorecer          el  “browning” (empardecimiento)                   del\n     tejido adiposo blanco, incrementando el gasto energético. También aumenta la sensibilidad\n     de la insulina, aumenta la adiponectina o disminuye las concentraciones de leptina\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}